On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch ...
Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and ...
Biobanking market size was valued at USD 72 billion in 2023 to USD 95.5 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-20 ...
Tesla (TSLA) rallied by +14.8% to lead gainers in the Nasdaq 100 on speculation the company will be ... Kenvue Inc (KVUE), Mettler-Toledo International Inc (MTD), Moderna Inc (MRNA), Molson Coors ...
Tesla (TSLA) surged over +14% and was the top percentage gainer on the Nasdaq 100 amid speculation that the company ... (CCJ), Expedia (EXPE), Warner Bros Discovery (WBD), Moderna (MRNA), Carlyle ...
Based on its deep expertise in mRNA vaccine development and in-house manufacturing ... MAINZ, Germany I November 13, 2024 I BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) today ...
Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines.
Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...
In September, we started enrollment in our Phase 2b study evaluating our COVID-19 oral pill vaccine candidate against an approved mRNA vaccine comparator. Interest for our trial is strong and it is ...
"Vergent concludes enrolment for lung cancer study of VGT-309" was originally created and published by Clinical Trials Arena, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...